Nintedanib Impurity 7 (Intedanib Impurity 7)
|
尼達(dá)尼布雜質(zhì)7(阿達(dá)尼雜質(zhì)7)
|
|
Hydrocortisone Impurity 2
|
氫化可的松雜質(zhì)2
|
|
Piracetam Impurity 7
|
吡拉西坦雜質(zhì)7
|
|
Lenalidomide Impurity 1
|
來(lái)那度胺雜質(zhì)1
|
874760-72-2
|
Febuxostat Impurity 63
|
非布司他雜質(zhì)63
|
1335202-59-9
|
Sorafenib related compound 12
|
索拉非尼相關(guān)化合物12
|
2004659-84-9
|
Sorafenib Impurity 10
|
索拉非尼雜質(zhì)10
|
|
Indacaterol Impurity 12
|
茚達(dá)特羅雜質(zhì)12對(duì)照品
|
773895-24-2
|
Metoclopramide Impurity 6
|
甲氧氯普胺雜質(zhì)6
|
|
Vonoprazan Impurity 44 Fumarate
|
沃諾拉贊雜質(zhì) 44富馬酸鹽
|
|
Lansoprazole Impurity 24
|
蘭索拉唑雜質(zhì)24
|
|
Formoterol Impurity 36
|
福莫特羅雜質(zhì)36對(duì)照品
|
40101-17-5
|
Parecoxib Impurity 47
|
帕瑞昔布雜質(zhì)47
|
|
Prednisone Impurity 28 (20(S)-Hydroxy Methylprednisolone)
|
潑尼松雜質(zhì)28(20(S)-羥基甲潑尼松)
|
387-66-6
|
Rasagiline Impurity 3
|
雷沙吉蘭雜質(zhì)3 HCl
|
1175018-74-2
|
Vonoprazan Impurity 21
|
沃諾拉贊雜質(zhì)21
|
|
Nintedanib Impurity 62 DiHCl
|
尼達(dá)尼布雜質(zhì)62二鹽酸對(duì)照品
|
5395-70-0
|
Metoprolol Impurity 1 HCl
|
美托洛爾雜質(zhì)11鹽酸鹽
|
83281-59-8
|
Aripiprazole Impurity 30
|
阿立哌唑雜質(zhì)30
|
48121-20-6
|
Paroxetine Impurity 20
|
帕羅西汀雜質(zhì)20
|
318279-38-8
|
Lenalidomide Impurity 48
|
來(lái)那度胺雜質(zhì)48
|
|
Paroxetine Related Impurity 8
|
帕羅西汀相關(guān)雜質(zhì)8
|
|
(2,4-Dinitro-5-fluorophenyl) L-Alaninamide
|
(2,4-二硝基-5-氟苯基)L-丙氨酰胺對(duì)照品
|
95713-52-3
|
(R,S)-Labetalol HCl
|
(R,S)-鹽酸拉貝洛爾
|
81602-13-3
|
Methylprednisolone Impurity 3
|
甲潑尼松雜質(zhì)3
|
|
Budesonide Impurity 11
|
布地奈德雜質(zhì)11
|
39672-76-9
|
Pregabalin Impurity 41
|
普瑞巴林雜質(zhì)41對(duì)照品
|
|
Febuxostat Impurity 74
|
非布司他雜質(zhì)74
|
|
Budesonide Impurity 18
|
布地奈德雜質(zhì)18
|
95943-95-6
|
Paliperidone Impurity 7
|
帕利哌酮雜質(zhì)7
|
1415488-05-9
|
Formoterol EP Impurity F (Mixture of Diastereomers) Diformate
|
福莫特羅 EP 雜質(zhì) F(非對(duì)映體混合物)變形對(duì)照品
|
1795129-59-7
|
Nintedanib Impurity 36
|
尼達(dá)尼布雜質(zhì)36對(duì)照品
|
|
(R)-alfa-Methylbenzylamine
|
(R)-α-甲基芐胺對(duì)照品
|
3886-69-9
|
Metoclopramide EP Impurity D (Metoclopramide USP Related Compound D)
|
甲氧氯普胺EP雜質(zhì)D(胃復(fù)安USP相關(guān)化合物D)
|
4093-29-2
|
Prednisolone Impurity 2
|
潑尼松龍雜質(zhì)2
|
|
Pregabalin Impurity 25
|
普瑞巴林雜質(zhì)25
|
|
Nintedanib Impurity 53
|
尼達(dá)尼布雜質(zhì)53對(duì)照品
|
334952-09-9
|
Brivaracetam Impurity 39
|
布瓦西坦雜質(zhì)39
|
63095-60-3
|
Fludrocortisone Acetate
|
醋酸氟氫可的松
|
514-36-3
|
Nintedanib Impurity 98
|
尼達(dá)尼布雜質(zhì)98對(duì)照品
|
14192-26-8
|
Regorafenib Impurity 23
|
瑞戈非尼雜質(zhì)23
|
|
Nebivolol Impurity 12 HCl (RR,RR)
|
奈比洛爾雜質(zhì)12 HCl(RR,RR)
|
920275-25-8
|
Regorafenib Impurity 22
|
瑞戈非尼雜質(zhì)22
|
39893-50-0
|
Paroxetine Impurity 31
|
帕羅西汀雜質(zhì)31
|
2105932-71-4
|
Hydrocortisone Impurity 6
|
氫化可的松雜質(zhì)6
|
136370-31-5
|
Moxifloxacin Impurity 2
|
莫西沙星雜質(zhì)2
|
|
Ipratropium Bromide Impurity 10 HCl
|
異丙托溴銨雜質(zhì)10鹽酸鹽
|
|
Hydrocortisone Impurity 8
|
氫化可的松雜質(zhì)8
|
|
Paroxetine Impurity 24
|
帕羅西汀雜質(zhì)24
|
|
Fluticasone Impurity (Cyclic thioester)
|
氟替卡松雜質(zhì)(環(huán)硫酯)
|
|
Nebivolol Impurity 21 (Mixture of Diastereomers)
|
奈比洛爾雜質(zhì)21(雙立體異構(gòu)體混合物)
|
99199-90-3
|
Lurasidone Impurity 8 Sodium Salt (Mixture of Diastereomers)
|
魯拉西酮雜質(zhì)8鈉鹽(雙立體異構(gòu)體混合物)
|
|
Nebivolol Impurity 37
|
奈比洛爾雜質(zhì)37
|
1030385-17-1
|
Lenalidomide Impurity 43
|
來(lái)那度胺雜質(zhì)43
|
2197414-56-3
|
Fluticasone Impurity 23
|
氟替卡松雜質(zhì)23
|
|
Paroxetine Impurity 22
|
帕羅西汀雜質(zhì)22
|
|
delta-9(11)-Hydrocortisone Acetate (Anecortave Acetate)
|
δ-9(11)-醋酸氫化可的松(醋酸Anecortave)
|
7753-60-8
|
Betamethasone Impurity 26
|
倍他米松雜質(zhì)26
|
52619-21-3
|
Hydrocortisone Impurity 14
|
氫化可的松雜質(zhì)14
|
|
24-Hydroxy Budesonide (Mixture of Diastereomers)
|
24-羥基布地奈德(雙立體異構(gòu)體的混合物)
|
|
Lenalidomide Impurity 41
|
來(lái)那度胺雜質(zhì)41
|
|
Febuxostat Impurity 56
|
非布司他雜質(zhì)56
|
|
Formoterol Hemifumarate
|
福莫特羅半富馬酸鹽對(duì)照品
|
|
O-Desmethyl Pantoprazole O-Sulfate
|
O-去甲基泮托拉唑O-硫酸酯
|
|
Pantoprazole Impurity 59
|
泮托拉唑雜質(zhì)59
|
562074-62-8
|
Budesonide Impurity 20
|
布地奈德雜質(zhì)20
|
|
Budesonide Impurity 27
|
布地奈德雜質(zhì)27
|
1234572-34-9
|
Ilaprazole Impurity 23
|
艾普拉唑雜質(zhì)23
|
2285346-40-7
|
Ilaprazole Impurity 7
|
艾普拉唑雜質(zhì)7
|
|
R-Lenalidomide
|
R-來(lái)那度胺
|
874946-00-6
|
Pantoprazole Impurity 11 DiHCl
|
泮托拉唑雜質(zhì)11
|
97963-77-4
|
Hydrocortisone Impurity 42
|
氫化可的松雜質(zhì)42
|
|
Budesonide Impurity 29
|
布地奈德雜質(zhì)29
|
|
Lansoprazole Impurity 31
|
蘭索拉唑雜質(zhì)31
|
60373-71-9
|
Pregabalin Impurity 60
|
普瑞巴林雜質(zhì)60
|
959143-48-7
|
Metoclopramide Impurity 17
|
甲氧氯普胺雜質(zhì)17
|
105-04-4
|
Nebivolol Impurity 59
|
奈比洛爾雜質(zhì)59
|
1017878-67-9
|
Paroxetine Impurity 28
|
帕羅西汀雜質(zhì)28
|
105812-81-5
|
Famotidine-15N2-13C
|
法莫替丁-15N2-13C
|
76824-35-6
|
Moxifloxacin Impurity 101
|
莫西沙星雜質(zhì)101
|
1413927-17-9
|
Brivaracetam Impurity 15
((S)-4-Benzyl-2-oxazolidinone)
|
布瓦西坦雜質(zhì)15對(duì)照品
(索利安非托雜質(zhì)5)
|
90719-32-7
|
Bisoprolol Impurity 7
|
比索洛爾雜質(zhì)7
|
|
Piracetam Impurity 3 (2-Chloroacetamide)
|
吡拉西坦雜質(zhì)3(2-氯乙酰胺)
|
|
Pregabalin Impurity 59
|
普瑞巴林雜質(zhì)59對(duì)照品
|
|
Moxifloxacin Impurity 22 HCl
|
莫西沙星雜質(zhì)22HCl
|
|
Pantoprazole Impurity 25
|
泮托拉唑雜質(zhì)25
|
|
Rasagiline Impurity 30
|
雷沙吉蘭雜質(zhì)30對(duì)照品
|
151252-98-1
|
Procaterol Impurity 19
|
丙卡特羅雜質(zhì)19
|
103702-26-7
|
Lacosamide Impurity 20
|
拉科酰胺雜質(zhì)20對(duì)照品
|
2295925-91-4
|
Betamethasone Impurity 54
|
倍他米松雜質(zhì)54
|
|
Arotinolol Impurity ZY2
|
阿羅洛爾雜質(zhì)ZY2
|
1365760-23-1
|
Sorafenib Impurity 19
|
索拉非尼雜質(zhì)19
|
952490-71-0
|
Loxoprofen Impurity 61
|
洛索洛芬雜質(zhì)61
|
1152440-23-7
|
Loxoprofen Related Compound 11
|
洛索洛芬相關(guān)化合物11
|
|
Hydrocortisone Impurity 24
|
氫化可的松雜質(zhì)24
|
|
Bisoprolol Impurity 27
|
比索洛爾雜質(zhì)27
|
|
Metoclopramide Impurity 14
|
甲氧氯普胺雜質(zhì)14
|
3761-48-6
|
Bumetanide Impurity 20
|
布美他尼雜質(zhì)20
|
688047-81-6
|
Prednisolone Impurity 42
|
潑尼松龍雜質(zhì)42
|
106822-21-3
|
Prednisolone Impurity 43
|
潑尼松龍雜質(zhì)43
|
95440-71-4
|